Consensus Walgreens Boots Alliance, Inc.

Equities

WBA

US9314271084

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
17.59 ^USD	-0.23%		-2.71%	-32.63%

Apr. 15	Truist Securities Adjusts Price Target on Walgreens Boots Alliance to $20 From $25	MT
Apr. 12	RBC Capital Cuts Walgreens Boots Alliance's Price Target to $22 From $26, Sector Perform Rating Kept	MT

Evolution of the average Target Price on Walgreens Boots Alliance, Inc.

Price target over the last 5 years

History of analyst recommendation changes

9b6e8f1615.KbBdrXMHyDwD0KYVDfd7IGEiy7WW1o-BaOqPHapNd3s.f8IJ9Sx9jAU7ocMnWJwBTFd7gcLEt_juUZDrK_wYNkxD-i30OFi-cDWb1Q~c7e23fed11d1b3c6395419fb99f8a054

Analyst Recommendations on Walgreens Boots Alliance, Inc.

Truist Securities Adjusts Price Target on Walgreens Boots Alliance to $20 From $25	Apr. 15	MT
RBC Capital Cuts Walgreens Boots Alliance's Price Target to $22 From $26, Sector Perform Rating Kept	Apr. 12	MT
UBS Cuts Walgreens Boots Alliance's Price Target to $22 From $25, Maintains Neutral Rating	Apr. 03	MT
Top Midday Stories: Bankman-Fried Gets 25-Year Prison Sentence; Home Depot Acquiring SRS Distribution; Walgreens Lowers FY 2024 Outlook; Analyst Says Short MicroStrategy; Canadian School Boards Sue Social Media Platforms; Eli Lilly Weight-Loss Drug Facing Shortage	Mar. 28	MT
BofA Securities Trims Walgreens Boots Alliance's Price Target to $22 From $23, Maintains Underperform Rating	Mar. 26	MT
Morgan Stanley Trims Price Target on Walgreens Boots Alliance to $21 From $22, Keeps Underweight Rating	Mar. 26	MT
Leerink Partners Adjusts Price Target on Walgreens Boots Alliance to $22 From $23, Maintains Market Perform Rating	Mar. 18	MT
Leerink Partners Initiates Walgreens Boots Alliance at Market Perform Rating With $23 Price Target	Feb. 26	MT
HSBC Downgrades Walgreens Boots Alliance to Reduce From Hold, Adjusts Price Target to $20 From $27	Feb. 20	MT
Deutsche Bank Cuts Price Target on Walgreens Boots Alliance to $23 From $27, Maintains Hold Rating	Jan. 05	MT
WALGREENS BOOTS ALLIANCE : UBS gives a Neutral rating	Jan. 04	ZD
HSBC Starts Walgreens Boots Alliance With Hold Rating, $27 Price Target	Dec. 22	MT
Health Care Up on Rate-Sensitive Sector Bias -- Health Care Roundup	Nov. 14	DJ
JPMorgan Upgrades Walgreens Boots Alliance to Overweight From Neutral, Raises Price Target to $30 From $27	23-10-23	MT
ANALYST RECOMMENDATIONS : Amazon, Procter & Gamble, Salesforce, Unilever, Walgreens Boots...	23-10-23
RBC Cuts Price Target on Walgreens Boots Alliance to $26 From $29, Keeps Sector Perform Rating	23-10-13	MT
UBS Adjusts Walgreens Boots Alliance Price Target to $25 From $32, Maintains Neutral Rating	23-10-11	MT
Rose-colored glasses are back	23-10-11
Earnings season starts with PepsiCo	23-10-10
Earnings season starts with PepsiCo	23-10-10
Mizuho Securities Adjusts Price Target on Walgreens Boots Alliance to $25 From $31, Keeps Neutral Rating	23-10-10	MT
ANALYST RECOMMENDATIONS : Dollar General, Estee Lauder, ResMed, Tesla, Ulta Beauty...	23-10-10
JPMorgan Cuts Price Target on Walgreens Boots Alliance to $27 From $33, Maintains Neutral Rating	23-10-05	MT
TD Cowen Adjusts Walgreens Boots Alliance's Price Target to $37 From $41, Keeps Outperform Rating	23-09-28	MT
Deutsche Bank Adjusts Walgreens Boots Alliance Price Target to $27 From $34, Maintains Hold Rating	23-09-22	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

17.63 USD

Average target price

23.34 USD

Spread / Average Target

+32.37%

High Price Target

35 USD

Spread / Highest target

+98.53%

Low Price Target

18 USD

Spread / Lowest Target

+2.10%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Walgreens Boots Alliance, Inc.

Truist Securities
RBC Capital Markets
UBS
BofA Securities
Morgan Stanley
Leerink Partners
HSBC
Deutsche Bank Securities
JPMorgan Chase
Mizuho Securities
TD Cowen
Credit Suisse
Barclays
Evercore ISI
Loop Capital
Cowen
Argus
Baird
J.P. Morgan Chase
Goldman Sachs

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar